194 related articles for article (PubMed ID: 1305473)
21. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
Janakiram NB; Steele VE; Rao CV
Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
[TBL] [Abstract][Full Text] [Related]
22. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
Reddy BS; Rivenson A; Kulkarni N; Upadhyaya P; el-Bayoumy K
Cancer Res; 1992 Oct; 52(20):5635-40. PubMed ID: 1394188
[TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.
Earnest DL; Holubec H; Wali RK; Jolley CS; Bissonette M; Bhattacharyya AK; Roy H; Khare S; Brasitus TA
Cancer Res; 1994 Oct; 54(19):5071-4. PubMed ID: 7923119
[TBL] [Abstract][Full Text] [Related]
24. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
[TBL] [Abstract][Full Text] [Related]
25. Effect of the chemopreventive agents piroxicam and D,L-alpha-difluoromethylornithine on intermediate biomarkers of colon carcinogenesis.
Kulkarni N; Zang E; Kelloff G; Reddy BS
Carcinogenesis; 1992 Jun; 13(6):995-1000. PubMed ID: 1600622
[TBL] [Abstract][Full Text] [Related]
26. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
Femia AP; Dolara P; Caderni G
Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of experimental colon cancer by genistein.
Rao CV; Wang CX; Simi B; Lubet R; Kelloff G; Steele V; Reddy BS
Cancer Res; 1997 Sep; 57(17):3717-22. PubMed ID: 9288778
[TBL] [Abstract][Full Text] [Related]
28. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of azoxymethane-induced colonic mucosal ornithine decarboxylase and tyrosine kinase activity by calcium in rats.
Arlow FL; Walczak SM; Luk GD; Majumdar AP
Cancer Res; 1989 Nov; 49(21):5884-8. PubMed ID: 2790802
[TBL] [Abstract][Full Text] [Related]
30. Kinetic changes in mucosal ornithine decarboxylase activity during azoxymethane-induced colonic carcinogenesis in the rat.
Luk GD; Hamilton SR; Yang P; Smith JA; O'Ceallaigh D; McAvinchey D; Hyland J
Cancer Res; 1986 Sep; 46(9):4449-52. PubMed ID: 3731101
[TBL] [Abstract][Full Text] [Related]
31. Alpha-difluoromethylornithine-induced inhibition of growth of autochthonous experimental colonic tumors produced by azoxymethane in male F344 rats.
Zhang SZ; Luk GD; Hamilton SR
Cancer Res; 1988 Nov; 48(22):6498-503. PubMed ID: 3141045
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Rao CV; Seibert K
Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
[TBL] [Abstract][Full Text] [Related]
33. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.
Kawamori T; Lubet R; Steele VE; Kelloff GJ; Kaskey RB; Rao CV; Reddy BS
Cancer Res; 1999 Feb; 59(3):597-601. PubMed ID: 9973206
[TBL] [Abstract][Full Text] [Related]
34. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats.
Reddy BS; Sugie S
Cancer Res; 1988 Dec; 48(23):6642-7. PubMed ID: 3180073
[TBL] [Abstract][Full Text] [Related]
35. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil.
Nigro ND; Bull AW; Boyd ME
J Natl Cancer Inst; 1986 Dec; 77(6):1309-13. PubMed ID: 3099048
[TBL] [Abstract][Full Text] [Related]
37. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon.
Rao CV; Simi B; Reddy BS
Carcinogenesis; 1993 Nov; 14(11):2219-25. PubMed ID: 8242846
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer.
Reddy BS; Wynn TT; el-Bayoumy K; Upadhyaya P; Fiala E; Rao CV
Anticancer Res; 1996; 16(3A):1123-7. PubMed ID: 8702223
[TBL] [Abstract][Full Text] [Related]
39. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
[TBL] [Abstract][Full Text] [Related]
40. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
